Study pinpoints what causes relapse after cancer immunotherapy

by Elaine Fuchs,Rockefeller UniversityKiller T cells surround a cancer cell. Credit: NIHHarnessing the body's immune system to fight off cancer, a tactic known as immunotherapy, has tremendo

Updated on: May 25,2024

Study pinpoints what causes relapse after cancer immunotherapy

by Elaine Fuchs,Rockefeller UniversityKiller T cells surround a cancer cell. Credit: NIHHarnessing the body's immune system to fight off cancer, a tactic known as immunotherapy, has tremendo

Updated on:May 25,2024

Evolving insights in blood-based liquid biopsies for prostate cancer interrogation

by Impact Journals LLCAnalysis of blood-based liquid biopsies in prostate cancer. Credit:Oncoscience(2023). DOI: 10.18632/oncoscience.592A new research perspective was published inOn

Updated on: January 02,2024

Evolving insights in blood-based liquid biopsies for prostate cancer interrogation

by Impact Journals LLCAnalysis of blood-based liquid biopsies in prostate cancer. Credit:Oncoscience(2023). DOI: 10.18632/oncoscience.592A new research perspective was published inOn

Updated on:January 02,2024

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed

Updated on: April 09,2024

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed

Updated on:April 09,2024

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c

Updated on: January 23,2024

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c

Updated on:January 23,2024

Researchers show xCT protein is key link in inhibiting pancreatic cancer growth and limiting mood disturbances

by Vrije Universiteit BrusselCredit: Pixabay/CC0 Public DomainThe xCT protein, which plays an important role as a transport molecule in cells, could play a part in cancer treatment in the future, rese

Updated on: March 28,2024

Researchers show xCT protein is key link in inhibiting pancreatic cancer growth and limiting mood disturbances

by Vrije Universiteit BrusselCredit: Pixabay/CC0 Public DomainThe xCT protein, which plays an important role as a transport molecule in cells, could play a part in cancer treatment in the future, rese

Updated on:March 28,2024

Targeted cancer drug made available for some NHS liver cancer patients

by Cancer Research UKCredit: CC0 Public DomainA targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.Regorafenib (Stivarga) is to be offered to people

Updated on: March 09,2024

Targeted cancer drug made available for some NHS liver cancer patients

by Cancer Research UKCredit: CC0 Public DomainA targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.Regorafenib (Stivarga) is to be offered to people

Updated on:March 09,2024

Prostate cancer diagnosis later for Kiwi men

by Anna Kellett,University of AucklandDr Nishi Karunasinghe. Credit: University of AucklandNew Zealand men are being diagnosed with prostate cancer later in life at a higher prostate-specific an

Updated on: March 01,2024

Prostate cancer diagnosis later for Kiwi men

by Anna Kellett,University of AucklandDr Nishi Karunasinghe. Credit: University of AucklandNew Zealand men are being diagnosed with prostate cancer later in life at a higher prostate-specific an

Updated on:March 01,2024

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on: March 30,2024

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on:March 30,2024

Telerehabilitation aids function, pain with advanced cancer

(HealthDay)—Collaborative telerehabilitation modestly improves function and pain while decreasing hospital length of stay and the need for postacute care in advanced cancer patients, according to a st

Updated on: May 05,2024

Telerehabilitation aids function, pain with advanced cancer

(HealthDay)—Collaborative telerehabilitation modestly improves function and pain while decreasing hospital length of stay and the need for postacute care in advanced cancer patients, according to a st

Updated on:May 05,2024

Most survivors of childhood cancer don't get the tests needed to detect serious long-term adverse effects, finds study

by Canadian Medical Association JournalCredit: CC0 Public DomainSurviving childhood cancer does not always mean a clean bill of health, as the treatments that eradicate those cancers can put adul

Updated on: March 20,2024

Most survivors of childhood cancer don't get the tests needed to detect serious long-term adverse effects, finds study

by Canadian Medical Association JournalCredit: CC0 Public DomainSurviving childhood cancer does not always mean a clean bill of health, as the treatments that eradicate those cancers can put adul

Updated on:March 20,2024

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on: April 10,2024

Treating the TOTAL patient: clinical trial reduces relapse

by St. Jude Children's Research HospitalSima Jeha, M.D., of the St. Jude Departments of Oncology and Global Pediatric Medicine, and Ching-Hon Pui, M.D., chair of the St. Jude Department of On

Updated on:April 10,2024

Those with the BRCA1 gene mutation may face greater risk for aggressive cancer caused by asbestos exposure

byNagoya UniversityChrysotile-induced MMs present lower expression levels of Brca1. (A) Immunohistochemistry (IHC) staining of total BRCA1 on MM samples (bar=25 μm; N≧7).

Updated on: January 02,2024

Those with the BRCA1 gene mutation may face greater risk for aggressive cancer caused by asbestos exposure

byNagoya UniversityChrysotile-induced MMs present lower expression levels of Brca1. (A) Immunohistochemistry (IHC) staining of total BRCA1 on MM samples (bar=25 μm; N≧7).

Updated on:January 02,2024